• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.33 número4

Has 10000 "Rev. Bras. Hematol. Hemoter. vol.33 número4" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.33 número4".

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Universidade de Campinas – UNICAMP, Campinas, SP, Brazil Presidente da Associação Brasileira de Hematologia e Hemoterapia – ABHH. Cármino Antonio de Souza.[r] ... See full document

1

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... In the revised 2008 WHO diagnostic criteria for myeloproliferative neoplasms, mutation screening for JAK2V617F is considered a major criterion for polycythemia vera diagnosis and also fo[r] ... See full document

7

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Objective: The aim of this study was to evaluate some cellular activation markers on circulating mononuclear cells (CD38 and HLA-DR) in patients submitted to hematopoietic stem cell tra[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... This is a descriptive study of the population of newborn babies in São Carlos submitted to neonatal screening tests between 2007 and 2010 in the entire government healthcare network.. Th[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Departments of Hematology and Hematology and Pathology of the Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP) and the Instituto do Câncer do Estado de S[r] ... See full document

1

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... 7. Haddad E, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E, et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood. 1995;85(11):3328-33. 8. ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node: a report of four cases and review of the literature. Pulsoni A, Anghel G, Falcucci [r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Studies with neurons that contain Cgb showed that these cells become more resistant to attack by free radicals and reactive oxygen and nitrogen species in a mechanism similar to that des[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... 32. Schleyer E, Pursche S, Köhne CH, Schuler U, Renner U, Gschaidmeier H, et al. Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Repulsive force is generated by negative charges on the red blood cell surface that occur due to the presence of the carboxyl group of sialic acids in the cell membrane; these charges cr[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Ancillary therapy and supportive care of chronic graft-versus- host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-[r] ... See full document

7

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... 20. Pedrazzani ES, Cordeiro AM, Furquim CE, Souza FF. Implantação de um banco de dados em vacinação: experiência desenvolvida em um projeto de integração. Rev Latino Am Enferm. 2002;10(6): 831-6. 21. Frauches DO, ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Background: Recently, single nucleotide polymorphisms (SNPs) were identified in the promoter region of the perforin gene (PRF1) and it was found that the -398T mutant allele is correlat[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... In the univariate analysis, considering serological status as the dependent variable, only donation type (first time or return) was statistically significant for the donors who had their[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Background: Plasma components of group O blood donations are rarely submitted to ABO antibody titrations even though it is well known that passively acquired antibodies may destroy the [r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Monitoring of CD38high expression in peripheral blood CD8 + lymphocytes in patients after kidney transplantation as a marker of cytomegalovirus infection. Lino VA, Santos SM, Bittencour[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... present their evaluation of the use of confidential donation confirmation (CDC), i.e., release of blood units from donors who have confirmed that their blood may be used for transfusion [r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... Their work suggests that targeting ABO incompatible plasma and platelets from older males would lower the risk, if one assumes titers over 64 by the doubling- dilution method (generally [r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... (6) present an analysis of the frequency of the C398T polymorphism in a cohort of 62 patients with hematological cancers that had no allelic disequilibrium when compared to control popu[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.33 número4

Rev. Bras. Hematol. Hemoter. vol.33 número4

... A multicenter feasibility study of chronic graft- versus-host disease according to the National Institute of Health (NIH) criteria: efforts to establish a Brazil-Seattle consortium as a [r] ... See full document

2

Show all 10000 documents...